Centene Addresses ‘Challenges’ in California’s Medi-Cal Rx Launch

Centene CEO Sarah London addressed concerns surrounding a subsidiary’s implementation of California’s new Medicaid prescription drug program after news reports chronicled members struggling to get access and approvals to needed medications.

Continue reading here on HealthCare Dive.